XML 27 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurement
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair value measurement Refer to Note 2 of JPMorgan Chase’s 2020 Form 10-K for a discussion of the Firm’s valuation methodologies for assets, liabilities and lending-related commitments measured at fair value and the fair value hierarchy.
The following table presents the assets and liabilities reported at fair value as of September 30, 2021, and December 31, 2020, by major product category and fair value hierarchy.
Assets and liabilities measured at fair value on a recurring basis
Fair value hierarchy
Derivative
netting
adjustments
(f)
September 30, 2021 (in millions)Level 1Level 2Level 3Total fair value
Federal funds sold and securities purchased under resale agreements$ $273,158 $ $ $273,158 
Securities borrowed 72,833   72,833 
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)
 35,746 299  36,045 
Residential – nonagency 2,281 24  2,305 
Commercial – nonagency 1,662 19  1,681 
Total mortgage-backed securities 39,689 342  40,031 
U.S. Treasury, GSEs and government agencies(a)
87,623 9,282   96,905 
Obligations of U.S. states and municipalities 6,735 7  6,742 
Certificates of deposit, bankers’ acceptances and commercial paper
 2,567   2,567 
Non-U.S. government debt securities41,486 48,345 104  89,935 
Corporate debt securities 31,472 370  31,842 
Loans 6,359 982  7,341 
Asset-backed securities 2,569 28  2,597 
Total debt instruments129,109 147,018 1,833  277,960 
Equity securities124,349 1,658 634  126,641 
Physical commodities(b)
6,471 12,887   19,358 
Other 23,920 58  23,978 
Total debt and equity instruments(c)
259,929 185,483 2,525  447,937 
Derivative receivables:
Interest rate1,931 281,315 1,863 (260,343)24,766 
Credit 10,032 492 (9,349)1,175 
Foreign exchange235 162,182 779 (148,671)14,525 
Equity 71,346 3,076 (63,930)10,492 
Commodity 35,781 534 (19,365)16,950 
Total derivative receivables2,166 560,656 6,744 (501,658)67,908 
Total trading assets(d)
262,095 746,139 9,269 (501,658)515,845 
Available-for-sale securities:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)
 73,049   73,049 
Residential – nonagency 6,373   6,373 
Commercial – nonagency 3,132   3,132 
Total mortgage-backed securities 82,554   82,554 
U.S. Treasury and government agencies121,471    121,471 
Obligations of U.S. states and municipalities 17,515   17,515 
Non-U.S. government debt securities5,457 10,368   15,825 
Corporate debt securities 165 95  260 
Asset-backed securities:
Collateralized loan obligations 9,137   9,137 
Other 4,828   4,828 
Total available-for-sale securities126,928 124,567 95  251,590 
Loans (e)
 58,557 2,071  60,628 
Mortgage servicing rights  5,351  5,351 
Other assets(d)
9,332 4,061 321  13,714 
Total assets measured at fair value on a recurring basis$398,355 $1,279,315 $17,107 $(501,658)$1,193,119 
Deposits$ $9,431 $2,377 $ $11,808 
Federal funds purchased and securities loaned or sold under repurchase agreements
 187,439   187,439 
Short-term borrowings 17,622 2,411  20,033 
Trading liabilities:
Debt and equity instruments(c)
98,932 27,096 30  126,058 
Derivative payables:
Interest rate1,661 248,655 1,976 (243,460)8,832 
Credit 11,301 498 (10,406)1,393 
Foreign exchange248 160,511 1,336 (148,090)14,005 
Equity 79,924 6,913 (69,063)17,774 
Commodity 33,037 1,406 (22,962)11,481 
Total derivative payables1,909 533,428 12,129 (493,981)53,485 
Total trading liabilities100,841 560,524 12,159 (493,981)179,543 
Accounts payable and other liabilities4,957 332 51  5,340 
Beneficial interests issued by consolidated VIEs 99   99 
Long-term debt 52,985 23,514  76,499 
Total liabilities measured at fair value on a recurring basis$105,798 $828,432 $40,512 $(493,981)$480,761 
Fair value hierarchy
Derivative
netting
adjustments
(f)
December 31, 2020 (in millions)Level 1Level 2Level 3Total fair value
Federal funds sold and securities purchased under resale agreements$— $238,015 $— $— $238,015 
Securities borrowed— 52,983 — — 52,983 
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)
— 68,395 449 — 68,844 
Residential – nonagency— 2,138 28 — 2,166 
Commercial – nonagency— 1,327 — 1,330 
Total mortgage-backed securities— 71,860 480 — 72,340 
U.S. Treasury, GSEs and government agencies(a)
104,263 10,996 — — 115,259 
Obligations of U.S. states and municipalities— 7,184 — 7,192 
Certificates of deposit, bankers’ acceptances and commercial paper
— 1,230 — — 1,230 
Non-U.S. government debt securities26,772 40,671 182 — 67,625 
Corporate debt securities— 21,017 507 — 21,524 
Loans— 6,101 893 — 6,994 
Asset-backed securities— 2,304 28 — 2,332 
Total debt instruments131,035 161,363 2,098 — 294,496 
Equity securities97,035 2,652 476 
(g)
— 100,163 
Physical commodities(b)
6,382 5,189 — — 11,571 
Other— 21,351 
(g)
49 
(g)
— 21,400 
Total debt and equity instruments(c)
234,452 190,555 2,623 — 427,630 
Derivative receivables:
Interest rate(g)
2,318 387,023 

2,307 (355,923)35,725 
Credit(g)
— 12,721 624 (12,665)680 
Foreign exchange146 205,127 

987 (190,479)15,781 
Equity— 67,093 
(g)
3,519 (54,125)16,487 
Commodity— 21,272 231 (14,732)6,771 
Total derivative receivables2,464 693,236 

7,668 (627,924)75,444 
Total trading assets(d)
236,916 883,791 

10,291 (627,924)503,074 
Available-for-sale securities:
Mortgage-backed securities:
U.S. GSEs and government agencies(a)(g)
113,294 — — 113,301 
Residential – nonagency— 10,233 — — 10,233 
Commercial – nonagency— 2,856 — — 2,856 
Total mortgage-backed securities126,383 — — 126,390 
U.S. Treasury and government agencies201,951 — — — 201,951 
Obligations of U.S. states and municipalities— 20,396 — — 20,396 
Non-U.S. government debt securities13,135 9,793 — — 22,928 
Corporate debt securities— 216 — — 216 
Asset-backed securities:
Collateralized loan obligations— 10,048 — — 10,048 
Other— 6,249 — — 6,249 
Total available-for-sale securities215,093 173,085 — — 388,178 
Loans(e)
— 42,169 2,305 — 44,474 
Mortgage servicing rights— — 3,276 — 3,276 
Other assets(d)
8,110 4,561 538 — 13,209 
Total assets measured at fair value on a recurring basis$460,119 $1,394,604 

$16,410 

$(627,924)$1,243,209 
Deposits$— $11,571 $2,913 $— $14,484 
Federal funds purchased and securities loaned or sold under repurchase agreements
— 155,735 — — 155,735 
Short-term borrowings— 14,473 2,420 — 16,893 
Trading liabilities:
Debt and equity instruments(c)
82,669 16,838 51 — 99,558 
Derivative payables:
Interest rate(g)
2,496 349,442 

2,049 (340,975)13,012 
Credit(g)
— 13,984 

848 (12,837)1,995 
Foreign exchange132 214,373 

1,421 (194,493)21,433 
Equity— 74,032 

7,381 (55,515)25,898 
Commodity— 21,767 

962 (14,444)8,285 
Total derivative payables2,628 673,598 

12,661 (618,264)70,623 
Total trading liabilities85,297 690,436 

12,712 (618,264)170,181 
Accounts payable and other liabilities2,895 513 

68 — 3,476 
Beneficial interests issued by consolidated VIEs— 41 

— — 41 
Long-term debt— 53,420 

23,397 — 76,817 
Total liabilities measured at fair value on a recurring basis$88,192 $926,189 

$41,510 $(618,264)$437,627 
(a)At September 30, 2021, and December 31, 2020, included total U.S. GSE obligations of $68.6 billion and $117.6 billion, respectively, which were mortgage-related.
(b)Physical commodities inventories are generally accounted for at the lower of cost or net realizable value. “Net realizable value” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, net realizable value approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when net realizable value is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. Refer to Note 4 for a further discussion of the Firm’s hedge accounting relationships. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented.
(c)Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions).
(d)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At September 30, 2021, and December 31, 2020, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $813 million and $670 million, respectively. Included in these balances at September 30, 2021, and December 31, 2020, were trading assets of $56 million and $52 million, respectively, and other assets of $757 million and $618 million, respectively.
(e)At September 30, 2021, and December 31, 2020, included $27.2 billion and $15.1 billion, respectively, of residential first-lien mortgages, and $8.1 billion and $6.3 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. GSEs and government agencies of $13.1 billion and $8.4 billion, respectively.
(f)As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. The level 3 balances would be reduced if netting were applied, including the netting benefit associated with cash collateral.
(g)Prior-period amounts have been revised to conform with the current presentation.
Level 3 valuations
Refer to Note 2 of JPMorgan Chase’s 2020 Form 10-K for further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments.
The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and the weighted or arithmetic averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy.
The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value.
In the Firm’s view, the input range, weighted and arithmetic average values do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to-period and parameter-to-parameter based on the characteristics of the instruments held by the Firm at each balance sheet date.

Level 3 inputs(a)
September 30, 2021
Product/Instrument
Fair value
(in millions)
Principal valuation technique
Unobservable inputs(g)
Range of input values
Average(i)
Residential mortgage-backed securities and loans(b)
$1,161 Discounted cash flowsYield(2)%15%4%
Prepayment speed0%100%12%
Conditional default rate0%30%5%
Loss severity0%110%5%
Commercial mortgage-backed securities and loans(c)
480 Market comparablesPrice$0$100$84
Corporate debt securities465 Market comparablesPrice$2$150$95
Loans(d)
1,754 Market comparablesPrice$5$104$86
Asset-backed securities28 Market comparablesPrice$6$99$56
Net interest rate derivatives(118)Option pricingInterest rate volatility8bps569bps120bps
Interest rate spread volatility11bps23bps15bps
Interest rate correlation(65)%95%33%
IR-FX correlation(35)%50%(3)%
Discounted cash flowsPrepayment speed0%30%8%
Net credit derivatives(56)Discounted cash flowsCredit correlation33%63%45%
Credit spread1bps2,539 bps395bps
Recovery rate40%67%54%
Conditional default rate100%100%
Loss severity100%100%
50 Market comparablesPrice$0$115$78
Net foreign exchange derivatives(448)Option pricingIR-FX correlation(40)%65%21%
(109)Discounted cash flowsPrepayment speed9%9%9%
Net equity derivatives(3,837)Option pricing
Forward equity price(h)
61%123%99%
Equity volatility2%144%29%
Equity correlation12%100%55%
Equity-FX correlation(79)%59%(27)%
Equity-IR correlation15%50%28%
Net commodity derivatives(872)Option pricingOil Commodity Forward$635 / MT$850 / MT$743 / MT
Forward power price$24 / MWH$64 / MWH$44 / MWH
Commodity volatility2%142%72%
Commodity correlation(50)%77%14%
MSRs5,351 Discounted cash flowsRefer to Note 14
Long-term debt, short-term borrowings, and deposits(e)
27,319 Option pricingInterest rate volatility8bps569bps120bps
Interest rate correlation(65)%95%33%
IR-FX correlation(35)%50%(3)%
Equity correlation12%100%55%
Equity-FX correlation(79)%59%(27)%
Equity-IR correlation15%50%28%
983 Discounted cash flowsCredit correlation33%63%45%
Other level 3 assets and liabilities, net(f)
1,043 
(a)The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. Furthermore, the inputs presented for each valuation technique in the table are, in some cases, not applicable to every instrument valued using the technique as the characteristics of the instruments can differ.
(b)Comprises U.S. GSE and government agency securities of $299 million, nonagency securities of $24 million and non-trading loans of $838 million.
(c)Comprises nonagency securities of $19 million, trading loans of $41 million and non-trading loans of $420 million.
(d)Comprises trading loans of $941 million and non-trading loans of $813 million.
(e)Long-term debt, short-term borrowings and deposits include structured notes issued by the Firm that are financial instruments that typically contain embedded derivatives. The estimation of the fair value of structured notes includes the derivative features embedded within the instrument. The significant unobservable inputs are broadly consistent with those presented for derivative receivables.
(f)Includes equity securities of $1.0 billion including $379 million in Other Assets, for which quoted prices are not readily available and the fair value is generally based on internal valuation techniques such as EBITDA multiples and comparable analysis. All other level 3 assets and liabilities are insignificant both individually and in aggregate.
(g)Price is a significant unobservable input for certain instruments. When quoted market prices are not readily available, reliance is generally placed on price-based internal valuation techniques. The price input is expressed assuming a par value of $100.
(h)Forward equity price is expressed as a percentage of the current equity price.
(i)Amounts represent weighted averages except for derivative related inputs where arithmetic averages are used.
Changes in and ranges of unobservable inputs
Refer to Note 2 of JPMorgan Chase’s 2020 Form 10-K for a discussion of the impact on fair value of changes in unobservable inputs and the relationships between unobservable inputs as well as a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions.
Changes in level 3 recurring fair value measurements
The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the three and nine months ended September 30, 2021 and 2020. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable inputs to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments.
Fair value measurements using significant unobservable inputs
Three months ended
September 30, 2021
(in millions)
Fair value at
  July 1,
2021
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2021
Change in unrealized gains/(losses) related
to financial instruments held at September 30, 2021
Purchases(f)
Sales
Settlements(g)
Assets:(a)
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$329 $(12)$13 $(6)$(25)$ $ $299 $(12)
Residential – nonagency16  9  (1)  24 (1)
Commercial – nonagency
10 7 1  (13)14  19 6 
Total mortgage-backed securities
355 (5)23 (6)(39)14  342 (7)
Obligations of U.S. states and municipalities
8    (1)  7  
Non-U.S. government debt securities
183 (2)128 (98)  (107)104 (1)
Corporate debt securities487 (33)38 (115)(3)25 (29)370 (25)
Loans795  219 (197)(130)409 (114)982 2 
Asset-backed securities35 1 3 (4)  (7)28  
Total debt instruments1,863 (39)411 (420)(173)448 (257)1,833 (31)
Equity securities690 (41)5 (44) 62 (38)634 (34)
Other47 26 17  (31) (1)58 26 
Total trading assets – debt and equity instruments
2,600 (54)
(c)
433 (464)(204)510 (296)2,525 (39)
(c)
Net derivative receivables:(b)
Interest rate(22)618 21 (44)(683)13 (16)(113)246 
Credit(17)(9)4 (7)59 (4)(32)(6)(1)
Foreign exchange(583)2 28 (44)41 (5)4 (557)15 
Equity(4,936)723 192 (1,001)912 214 59 (3,837)397 
Commodity(1,167)88 130 (88)156 (2)11 (872)178 
Total net derivative receivables
(6,725)1,422 
(c)
375 (1,184)485 216 26 (5,385)835 
(c)
Available-for-sale securities:
Corporate debt securities  95     95  
Total available-for-sale securities
  

95     95  

Loans1,734 (13)
(c)
209 (1)(180)427 (105)2,071 (11)
(c)
Mortgage servicing rights4,549 (11)
(d)
1,013 1 (201)  5,351 (11)
(d)
Other assets518 (35)
(c)
3  (165)  321 (34)
(c)
Fair value measurements using significant unobservable inputs
Three months ended
September 30, 2021
(in millions)
Fair value at
  July 1,
2021
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2021
Change in unrealized (gains)/losses related
to financial instruments held at September 30, 2021
PurchasesSalesIssuances
Settlements(g)
Liabilities:(a)
Deposits$2,684 $(11)
(c)(e)
$ $ $33 $(172)$ $(157)$2,377 $(7)
(c)(e)
Short-term borrowings3,075 (699)
(c)(e)
  1,166 (1,121) (10)2,411 (124)
(c)(e)
Trading liabilities – debt and equity instruments
36 (2)
(c)
(8)2   3 (1)30 1 
(c)
Accounts payable and other liabilities
51  

      51 1 
(c)
Long-term debt23,527 (216)
(c)(e)
  2,950 (2,512)11 (246)23,514 (242)
(c)(e)
Fair value measurements using significant unobservable inputs
Three months ended
September 30, 2020
(in millions)
Fair value at
July 1,
2020
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2020
Change in unrealized gains/(losses) related
to financial instruments held at September 30, 2020
Purchases(f)
Sales
Settlements(g)
Assets:(a)
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$469 $(4)$110 $(28)$(40)$— $— $507 $(2)
Residential – nonagency23 — (2)(1)— (3)25 — 
Commercial – nonagency— — — — — — — 
Total mortgage-backed securities
494 (4)118 (30)(41)— (3)534 (2)
Obligations of U.S. states and municipalities
— — — — — — — 
Non-U.S. government debt securities
167 25 (23)(2)— (8)165 
Corporate debt securities946 45 114 (33)(225)(202)649 45 
Loans905 22 240 (173)(21)69 (312)730 
Asset-backed securities39 (21)(2)— 33 — 
Total debt instruments2,559 72 502 (280)(291)82 (525)2,119 57 
Equity securities191 24 13 (104)— 104 (42)186 29 
Other379 75 203 (4)(2)— 653 77 
Total trading assets – debt and equity instruments
3,129 171 
(c)
718 (388)(293)188 (567)2,958 163 
(c)
Net derivative receivables:(b)
Interest rate(104)657 15 (30)(647)

35 102 28 323 
Credit(137)(62)22 (16)154 (12)(49)(21)
Foreign exchange(595)(57)(7)(34)(676)(90)
Equity(2,036)(1,437)

323 (384)

29 

33 369 

(3,103)(1,051)
Commodity(297)15 11 (79)36 (302)(5)(621)39 
Total net derivative receivables
(3,169)(884)
(c)
378 (516)

(462)

(239)471 

(4,421)(800)
(c)
Available-for-sale securities:
Mortgage-backed securities— — 

— — 

— 

— — 

— — 
Total available-for-sale securities
— — 

— — — — — — — 

Loans1,874 (44)
(c)
197 (44)(324)316 (169)1,806 (44)
(c)
Mortgage servicing rights3,080 34 
(d)
221 (104)(215)— — 3,016 34 
(d)
Other assets701 (21)
(c)
— (27)— — 658 32 
(c)
Fair value measurements using significant unobservable inputs
Three months ended
September 30, 2020
(in millions)
Fair value at
July 1,
2020
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2020
Change in unrealized (gains)/losses related
to financial instruments held at September 30, 2020
PurchasesSalesIssuances
Settlements(g)
Liabilities:(a)
Deposits$3,217 $43 
(c)(e)
$— $— $170 $(110)$— $(264)$3,056 $87 
(c)(e)
Short-term borrowings2,305 (47)
(c)(e)
— — 1,421 (1,093)25 (3)2,608 (47)
(c)(e)
Trading liabilities – debt and equity instruments
59 (2)
(c)
(5)— (4)57 (3)
(c)
Accounts payable and other liabilities
91 
(c)
(62)— — — 44 
(c)
Beneficial interests issued by consolidated VIEs
— — 

— — — — — — — — 

Long-term debt22,728 766 
(c)(e)
— — 1,225 (2,493)

78 (88)22,216 

646 
(c)(e)
Fair value measurements using significant unobservable inputs
Nine months ended
September 30, 2021
(in millions)
Fair value at
January 1,
2021
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2021
Change in unrealized gains/(losses) related
to financial instruments held at September 30, 2021
Purchases(f)
Sales
Settlements(g)
Assets:(a)
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$449 $(22)$20 $(62)$(86)$$(1)$299 $(25)
Residential – nonagency28 24 (24)(4)— (1)24 (2)
Commercial – nonagency12 (1)(16)14 — 19 
Total mortgage-backed securities
480 (14)56 (87)(106)15 (2)342 (21)
Obligations of U.S. states and municipalities
— — — (1)— — — 
Non-U.S. government debt securities
182 (10)330 (284)(7)— (107)104 (2)
Corporate debt securities507 (18)357 (415)(3)138 (196)370 (3)
Loans893 785 (434)(256)584 (596)982 — 
Asset-backed securities28 41 (43)(1)(7)28 — 
Total debt instruments2,098 (28)1,569 (1,263)(374)739 (908)1,833 (26)
Equity securities476 (38)258 (114)— 140 (88)634 (92)
Other49 74 118 — (86)(100)58 37 
Total trading assets – debt and equity instruments
2,623 
(c)
1,945 (1,377)(460)882 (1,096)2,525 (81)
(c)
Net derivative receivables:(b)
Interest rate258 1,587 92 (146)(1,874)

68 (98)(113)212 
Credit(224)140 (11)103 (13)(7)(6)143 
Foreign exchange(434)(196)67 (98)140 (42)(557)(44)
Equity(3,862)(195)

667 (2,246)

1,638 

233 (72)

(3,837)(187)
Commodity(731)(505)140 (382)600 (3)(872)(223)
Total net derivative receivables
(4,993)831 
(c)
972 (2,883)

607 

291 (210)

(5,385)(99)
(c)
Available-for-sale securities:
Corporate debt securities— — 

95 — 

— 

— — 

95 — 
Total available-for-sale securities
— — 

95 — — — — 95 — 

Loans2,305 (79)
(c)
516 (326)(699)1,027 (673)2,071 (92)
(c)
Mortgage servicing rights3,276 258 
(d)
2,410 (23)(570)— — 5,351 258 
(d)
Other assets538 
(c)
10 (18)(217)— (1)321 22 
(c)
Fair value measurements using significant unobservable inputs
Nine months ended
September 30, 2021
(in millions)
Fair value at
January 1,
2021
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2021
Change in unrealized (gains)/losses related
to financial instruments held at September 30, 2021
PurchasesSalesIssuances
Settlements(g)
Liabilities:(a)
Deposits$2,913 $(67)
(c)(e)
$— $— $252 $(360)$$(363)$2,377 $(60)
(c)(e)
Short-term borrowings2,420 (1,095)
(c)(e)
— — 5,479 (4,333)(69)2,411 (117)
(c)(e)
Trading liabilities – debt and equity instruments
51 (6)
(c)
(100)36 — — 62 (13)30 (2)
(c)
Accounts payable and other liabilities
68 (10)
(c)
— — — — (8)51 (9)
(c)
Long-term debt23,397 190 
(c)(e)
— — 9,884 (9,250)

29 (736)23,514 

48 
(c)(e)
Fair value measurements using significant unobservable inputs
Nine months ended
September 30, 2020
(in millions)
Fair value at
Jan 1,
2020
Total realized/unrealized gains/(losses)Transfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2020
Change in unrealized gains/(losses) related
to financial instruments held at September 30, 2020
Purchases(f)
Sales
Settlements(g)
Assets:(a)
Trading assets:
Debt instruments:
Mortgage-backed securities:
U.S. GSEs and government agencies
$797 $(153)$134 $(149)$(122)$— $— $507 $(140)
Residential – nonagency23 (1)12 (4)(2)— (3)25 
Commercial – nonagency— — (1)(3)
Total mortgage-backed securities
824 (154)147 (153)(125)(6)534 (134)
Obligations of U.S. states and municipalities
10 — — (1)(1)— — — 
Non-U.S. government debt securities
155 10 164 (148)(7)— (9)165 
Corporate debt securities558 (10)475 (131)(234)296 (305)649 13 
Loans673 (72)829 (400)(130)676 (846)730 (35)
Asset-backed securities37 (4)42 (36)(5)(10)33 (1)
Total debt instruments2,257 (230)1,657 (869)(502)982 (1,176)2,119 (150)
Equity securities196 (79)37 (109)— 259 (118)186 (40)
Other232 239 213 (9)(23)(3)653 263 
Total trading assets – debt and equity instruments
2,685 (70)
(c)
1,907 (987)(525)1,245 (1,297)2,958 73 
(c)
Net derivative receivables:(b)
Interest rate(332)2,052 102 (97)(1,510)

(317)130 28 290 
Credit(139)— 70 (150)137 59 (26)(49)24 
Foreign exchange(607)(214)46 (16)75 15 25 (676)(181)
Equity(3,395)564 

912 (1,473)

558 

(524)255 

(3,103)1,342 
Commodity(16)(248)22 (107)54 (306)(20)(621)363 
Total net derivative receivables
(4,489)2,154 
(c)
1,152 (1,843)

(686)

(1,073)364 

(4,421)1,838 
(c)
Available-for-sale securities:
Mortgage-backed securities— 

— — 

(1)

— — 

— — 
Total available-for-sale securities
— 

— — (1)— — — — 

Loans516 (195)
(c)
450 (77)(678)2,312 (522)1,806 (147)
(c)
Mortgage servicing rights4,699 (1,459)
(d)
663 (177)(710)— — 3,016 (1,459)
(d)
Other assets917 (56)
(c)
66 (28)(281)40 — 658 
(c)
Fair value measurements using significant unobservable inputs
Nine months ended
September 30, 2020
(in millions)
Fair value at
Jan 1,
2020
Total realized/unrealized (gains)/lossesTransfers into
level 3
Transfers (out of) level 3Fair value at
September 30, 2020
Change in unrealized (gains)/losses related
to financial instruments held at September 30, 2020
PurchasesSalesIssuances
Settlements(g)
Liabilities:(a)
Deposits$3,360 $88 
(c)(e)
$— $— $636 $(538)$265 $(755)$3,056 $137 
(c)(e)
Short-term borrowings1,674 (294)
(c)(e)
— — 3,961 (2,769)77 (41)2,608 (27)
(c)(e)
Trading liabilities – debt and equity instruments
41 
(c)
(81)12 — (4)96 (8)57 — 

Accounts payable and other liabilities
45 (1)
(c)
(85)37 — — 48 — 44 
(c)
Long-term debt23,339 (639)
(c)(e)
— — 7,432 (7,851)

1,056 (1,121)22,216 

(507)
(c)(e)
(a)Level 3 assets at fair value as a percentage of total Firm assets at fair value (including assets measured at fair value on a nonrecurring basis) were 2% and 1% at September 30, 2021 and December 31, 2020, respectively. Level 3 liabilities at fair value as a percentage of total Firm liabilities at fair value (including liabilities measured at fair value on a nonrecurring basis) were 8% and 9% at September 30, 2021 and December 31, 2020, respectively.
(b)All level 3 derivatives are presented on a net basis, irrespective of the underlying counterparty.
(c)Predominantly reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans and lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income.
(d)Changes in fair value for MSRs are reported in mortgage fees and related income.
(e)Realized (gains)/losses due to DVA for fair value option elected liabilities are reported in principal transactions revenue, and were not material for the three and nine months ended September 30, 2021 and 2020. Unrealized (gains)/losses are reported in OCI, and were $318 million and $120 million for the three months ended September 30, 2021 and 2020, respectively, and $300 million and $(78) million for the nine months ended September 30, 2021 and 2020, respectively.
(f)Loan originations are included in purchases.
(g)Includes financial assets and liabilities that have matured, been partially or fully repaid, impacts of modifications, deconsolidations associated with beneficial interests in VIEs and other items.
Level 3 analysis
Consolidated balance sheets changes
The following describes significant changes to level 3 assets since December 31, 2020, for those items measured at fair value on a recurring basis. Refer to Assets and liabilities measured at fair value on a nonrecurring basis on page 109 for further information on changes impacting items measured at fair value on a nonrecurring basis.
Three and nine months ended September 30, 2021
Level 3 assets were $17.1 billion at September 30, 2021, reflecting an increase of $1.2 billion from June 30, 2021 and an increase of $697 million from December 31, 2020.
The increase for the three months ended September 30, 2021 was largely driven by an $802 million increase in MSRs.
The increase for the nine months ended September 30, 2021 was predominantly driven by:
a $2.1 billion increase in MSRs.
partially offset by
$444 million decrease in gross interest rate derivative receivables due to settlements net of gains and $443 million decrease in gross equity derivative receivables due to settlements and transfers net of gains.
Refer to Note 14 for information on MSRs.
Refer to the sections below for additional information.
Transfers between levels for instruments carried at fair value on a recurring basis
For the three months ended September 30, 2021, there were no significant transfers from level 2 into level 3.
For the nine months ended September 30, 2021, significant transfers from level 2 into level 3 included the following:
$882 million of total debt and equity instruments, largely trading loans, driven by a decrease in observability.
$937 million of gross equity derivative receivables and $704 million of gross equity derivative payables as a result of a decrease in observability and an increase in the significance of unobservable inputs.
$1.0 billion of non-trading loans driven by a decrease in observability.
For the three months ended September 30, 2021, there were no significant transfers from level 3 into level 2.
For the nine months ended September 30, 2021, significant transfers from level 3 into level 2 included the following:
$1.1 billion of total debt and equity instruments, largely trading loans, driven by an increase in observability.
$1.7 billion of gross equity derivative receivables and $1.6 billion of gross equity derivative payables as a result of an increase in observability and a decrease in the significance of unobservable inputs.
$673 million of non-trading loans, driven by an increase in observability.
$736 million of long-term debt driven, by an increase in observability and a decrease in the significance of unobservable inputs for certain structured notes.
For the three months ended September 30, 2020, there were no significant transfers from level 2 into level 3.
For the nine months ended September 30, 2020, significant transfers from level 2 into level 3 included the following:
$2.2 billion of gross equity derivative receivables and $2.7 billion of gross equity derivative payables as a result of a decrease in observability and an increase in the significance of unobservable inputs.
$2.3 billion of non-trading loans, driven by a decrease in observability.
$1.1 billion of long-term debt, driven by a decrease in observability and an increase in the significance of unobservable inputs for certain structured notes.
For the three months ended September 30, 2020, significant transfers from level 3 into level 2 included the following:
$965 million of gross equity derivative payables as a result of an increase in observability and a decrease in the significance of unobservable inputs.
For the nine months ended September 30, 2020, significant transfers from level 3 into level 2 included the following:
$1.7 billion of gross equity derivative receivables and $1.9 billion of gross equity derivative payables as a result of an increase in observability and a decrease in the significance of unobservable inputs.
$1.1 billion of long-term debt driven by an increase in observability and a decrease in the significance of unobservable inputs for certain structured notes.
All transfers are based on changes in the observability and/or significance of the valuation inputs and are assumed to occur at the beginning of the quarterly reporting period in which they occur.

Gains and losses
The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the periods indicated. These amounts exclude any effects of the Firm’s risk management activities where the financial instruments are classified as level 1 and 2 of the fair value hierarchy. Refer to Changes in level 3 recurring fair value measurements rollforward tables on pages 102-108 for further information on these instruments.
Three months ended September 30, 2021
$1.3 billion of net gains on assets, driven by gains in net interest rate derivative receivables and net equity derivative receivables due to market movements.
$928 million of net gains on liabilities, largely driven by gains in short-term borrowings due to market movements.
Three months ended September 30, 2020
$744 million of net losses on assets, driven by market movements in net equity derivative receivables.
$763 million of net losses on liabilities, driven by market movements in long-term debt.
Nine months ended September 30, 2021
$1.0 billion of net gains on assets, driven by gains in net interest rate derivative receivables due to market movements, partially offset by losses in net commodity derivative receivables due to market movements.
$988 million of net gains on liabilities, driven by gains in short-term borrowings due to market movements.
Nine months ended September 30, 2020
$374 million of net gains on assets, driven by gains in net interest rate derivative receivables due to market movements largely offset by losses in MSRs reflecting faster prepayment speeds on lower rates. Refer to Note 14 for additional information on MSRs.
$845 million of net gains on liabilities, predominantly driven by market movements in long-term debt.
Credit and funding adjustments — derivatives
The following table provides the impact of credit and funding adjustments on principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. The FVA presented below includes the impact of the Firm’s own credit quality on the inception value of liabilities as well as the impact of changes in the Firm’s own credit quality over time.
Three months ended September 30,Nine months ended September 30,
(in millions)2021202020212020
Credit and funding adjustments:
Derivatives CVA$60 $144 $343 $(574)
Derivatives FVA
38 109 99 (236)
Refer to Note 2 of JPMorgan Chase’s 2020 Form 10-K for further information about both credit and funding adjustments, as well as information about valuation adjustments on fair value option elected liabilities.
Assets and liabilities measured at fair value on a nonrecurring basis
The following tables present the assets and liabilities held as of September 30, 2021 and 2020, for which nonrecurring fair value adjustments were recorded during the nine months ended September 30, 2021 and 2020, by major product category and fair value hierarchy.
Fair value hierarchyTotal fair value
September 30, 2021 (in millions)
Level 1
Level 2
Level 3
Loans$ $1,175 

$314 
(b)
$1,489 
Other assets(a)
 7 1,202 1,209 
Total assets measured at fair value on a nonrecurring basis$ $1,182 $1,516 $2,698 
Accounts payable and other liabilities  2 
 
2 
Total liabilities measured at fair value on a nonrecurring basis$ $ $2 $2 
Fair value hierarchyTotal fair value
September 30, 2020 (in millions)Level 1Level 2Level 3
Loans$— $1,714 

$788 $2,502 
Other assets— 11 945 

956 
Total assets measured at fair value on a nonrecurring basis$— $1,725 $1,733 $3,458 
Accounts payable and other liabilities— — 

Total liabilities measured at fair value on a nonrecurring basis$— $— $$
(a)Primarily includes equity securities without readily determinable fair values that were adjusted based on observable price changes in orderly transactions from an identical or similar investment of the same issuer (measurement alternative). Of the $1.2 billion in level 3 assets measured at fair value on a nonrecurring basis as of September 30, 2021, $1.1 billion related to equity securities adjusted based on the measurement alternative. These equity securities are classified as level 3 due to the infrequency of the observable prices and/or the restrictions on the shares.
(b)Of the $314 million in level 3 assets measured at fair value on a nonrecurring basis as of September 30, 2021, $208 million related to residential real estate loans carried at the net realizable value of the underlying collateral (e.g., collateral-dependent loans). These amounts are classified as level 3 as they are valued using information from broker’s price opinions, appraisals and automated valuation models and discounted based upon the Firm’s experience with actual liquidation values. These discounts ranged from 12% to 45% with a weighted average of 25%.
Nonrecurring fair value changes
The following table presents the total change in value of assets and liabilities for which fair value adjustments have been recognized for the three and nine months ended September 30, 2021 and 2020, related to assets and liabilities held at those dates.
Three months ended September 30,Nine months ended September 30,
(in millions)2021202020212020
Loans$(10)
 
$(35)

$(40)

$(318)

Other assets(a)
84 
 
(363)

177 (539)
Accounts payable and other liabilities
 
 
92 

6 (3)
Total nonrecurring fair value gains/(losses)
$74 $(306)$143 $(860)
(a)Included $90 million and $2 million for the three months ended September 30, 2021 and 2020, respectively, and $197 million and $(155) million for the nine months ended September 30, 2021 and 2020, respectively, of net gains/(losses) as a result of the measurement alternative.
Refer to Note 11 for further information about the measurement of collateral-dependent loans.
Equity securities without readily determinable fair values
The Firm measures certain equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from an identical or similar investment of the same issuer, with such changes recognized in other income.
In its determination of the new carrying values upon observable price changes, the Firm may adjust the prices if deemed necessary to arrive at the Firm’s estimated fair values. Such adjustments may include adjustments to reflect the different rights and obligations of similar securities, and other adjustments that are consistent with the Firm’s valuation techniques for private equity direct investments.
The following table presents the carrying value of equity securities without readily determinable fair values held as of September 30, 2021 and 2020, that are measured under the measurement alternative and the related adjustments recorded during the periods presented for those securities with observable price changes. These securities are included in the nonrecurring fair value tables when applicable price changes are observable.
 Three months endedNine months ended
 September 30September 30
As of or for the period ended,
(in millions)2021202020212020
Other assets
Carrying value(a)
$3,207 $2,329 $3,207 $2,329 
Upward carrying value changes(b)
100 36 

216 49

Downward carrying value changes/impairment(c)
(10)(34)(18)(204)
(a)The carrying value as of December 31, 2020 was $2.4 billion. The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.
(b)The cumulative upward carrying value changes between January 1, 2018 and September 30, 2021 were $826 million.
(c)The cumulative downward carrying value changes/impairment between January 1, 2018 and September 30, 2021 were $(335) million.
Included in other assets above is the Firm’s interest in approximately 40 million Visa Class B common shares, recorded at a nominal carrying value. These shares are subject to certain transfer restrictions currently and will be convertible into Visa Class A common shares upon final resolution of certain litigation matters involving Visa. The conversion rate of Visa Class B common shares into Visa Class A common shares is 1.6228 at September 30, 2021, and may be adjusted by Visa depending on developments related to the litigation matters.
Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value
The following table presents, by fair value hierarchy classification, the carrying values and estimated fair values at September 30, 2021, and December 31, 2020, of financial assets and liabilities, excluding financial instruments that are carried at fair value on a recurring basis, and their classification within the fair value hierarchy.
September 30, 2021December 31, 2020
Estimated fair value hierarchyEstimated fair value hierarchy
(in billions)Carrying
value
Level 1Level 2Level 3Total estimated
fair value
Carrying
value
Level 1Level 2Level 3Total estimated
fair value
Financial assets
Cash and due from banks$25.9 $25.9 $ $ $25.9 $24.9 $24.9 $— $— $24.9 
Deposits with banks734.0 734.0   734.0 502.7 502.7 — — 502.7 
Accrued interest and accounts receivable
115.7  115.6 0.1 115.7 89.4 — 89.3 0.1 89.4 
Federal funds sold and securities purchased under resale agreements
9.0  9.0  9.0 58.3 — 58.3 — 58.3 
Securities borrowed
130.2  130.2  130.2 107.7 — 107.7 — 107.7 
Investment securities, held-to-maturity
343.5 181.3 163.1  344.4 201.8 53.2 152.3 — 205.5 
Loans, net of allowance for loan losses(a)
965.8  203.2 781.7 984.9 940.1 — 210.9 755.6 966.5 
Other98.0  96.7 1.4 98.1 81.8 — 80.0 1.9 81.9 
Financial liabilities
Deposits$2,390.5 $ $2,390.6 $ $2,390.6 $2,129.8 $— $2,128.9 $— $2,128.9 
Federal funds purchased and securities loaned or sold under repurchase agreements
67.5  67.5  67.5 59.5 — 59.5 — 59.5 
Short-term borrowings
30.4  30.4  30.4 28.3 — 28.3 — 28.3 
Accounts payable and other liabilities
228.6  224.0 4.2 228.2 186.6 — 181.9 4.3 186.2 
Beneficial interests issued by consolidated VIEs
13.2  13.2  13.2 17.5 — 17.6 — 17.6 
Long-term debt
221.9  225.6 3.3 228.9 204.8 — 209.2 3.2 212.4 
(a)Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. Carrying value of the loan takes into account the loan’s allowance for loan losses, which represents the loan’s expected credit losses over its remaining expected life. The difference between the estimated fair value and carrying value of a loan is generally attributable to changes in market interest rates, including credit spreads, market liquidity premiums and other factors that affect the fair value of a loan but do not affect its carrying value.
The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets. The carrying value and the estimated fair value of these wholesale lending-related commitments were as follows for the periods indicated.
September 30, 2021December 31, 2020
Estimated fair value hierarchyEstimated fair value hierarchy
(in billions)
Carrying value(a) (b)
Level 1Level 2Level 3Total estimated fair value
Carrying value(a) (b)
Level 1Level 2Level 3Total estimated fair value
Wholesale lending-related commitments
$2.1 $ $ $3.1 $3.1 $2.2 $— $— $2.1 $2.1 
(a)Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which is recognized at fair value at the inception of the guarantees.
(b)Includes the wholesale allowance for lending-related commitments.
The Firm does not estimate the fair value of consumer off-balance sheet lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases as permitted by law, without notice. Refer to page 173 of JPMorgan Chase’s 2020 Form 10-K for a further discussion of the valuation of lending-related commitments.